Taysha Gene Therapies, Inc. (TSHA)

Healthcare · Biotechnology · NASDAQ

Taysha Gene Therapies, Inc. (TSHA) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.89B and a free-cash-flow yield of -4.5%. Over the most recent reported fiscal year, revenue grew 17.3%.

Market cap	$1.89B
Trailing P/E	—
FCF yield	-4.5%
Revenue growth (YoY)	+17.3%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live TSHA data on Nama Insights →